Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Mission Bio
company
About
Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.
- San Francisco,California,United States
- 51 - 100
- http://www.missionbio.com
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $30M
- Industries
- Bioinformatics,Biotechnology,Genetics,Health Care
- Founded date
- Jan 1, 2012
- Number Of Employee
- 51 - 100
- Operating Status
- Active
- Legal Name
- Mission Bio, Inc.
- Also Known As
- Torrent Bio
Mission Bio delivers targeted solutions for high-impact applications with the Tapestri Platform. The Tapestri Platform is the industry’s first and only single-cell multi-omics platform, enabling genotype and phenotype from the same cell and precise detection of heterogeneity in disease progression and treatment response. Application areas include oncology blood cancers, solid tumors, and genome editing validation.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
9
$110.89M
Mission Bio has raised a total of
$110.89M
in funding over 2 rounds. Their latest funding was raised on
Aug 13, 2020 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 13, 2020 | Series C | $70M | 6 |
Novo Holdings
|
— | Detail |
| Mar 31, 2020 | Series Unknown | — | 1 | — | — | Detail |
| Mar 13, 2020 | Series C | — | 1 | — | — | Detail |
| Dec 13, 2018 | Series B | $30M | 5 | — | — | Detail |
| Jun 29, 2018 | Series Unknown | — | 21 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
1
Mission Bio has made 1 investments. Their most recent investment was on
Jun 1, 2016, when NEXAW raised $10K.
Investors
Number of Lead Investors
Number of Investors
4
27
Mission Bio is funded by 27 investors.
Novo Holdings
and Agilent Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Novo Holdings
|
Yes | Series C |
Agilent Ventures
|
— | Series C |
Cota Capital
|
— | Series C |
Mayfield Fund
|
— | Series C |
Seabed VC
|
— | Series C |
Soleus Capital
|
— | Series C |
Mighty Capital
|
— | Series Unknown |
Alumni Ventures
|
— | Series C |
LabCorp
|
— | Series B |
Agilent Technologies
|
— | Series B |
Employee Profiles
Number of Employee Profiles
10
Mission Bio has 10 current employee profiles, including
Board member Lu Zhang
Board member
Board member
Advisor
Executive
Advisor
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
